{"url_path":"/sec/wst/8-k/2026-05-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/105770/0000105770-26-000077-index.html","accession_number":"0000105770-26-000077","cik":"0000105770","ticker":"WST","issuer_name":"WEST PHARMACEUTICAL SERVICES INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/105770/0000105770-26-000077-index.html","primary_entity_key":"0000105770","primary_entity_name":"WEST PHARMACEUTICAL SERVICES INC"},"word_count":99,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d)\n\nExhibit No.\n\nDescription\n\n104\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n2\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: May 20, 2026\n\nWEST PHARMACEUTICAL SERVICES, INC.\n\nBy:\n/s/ Norman D. Finch Jr.\n\nNorman D. Finch Jr.\n\nSenior Vice President, General Counsel and Corporate Secretary\n\n3\n\nEXHIBIT INDEX\n\nExhibit No.\n\nDescription\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n4"}